AG-221 clinical trial
I am going to participate in the AG-221 clinical trial. It is specific to AML and MDS patients with an IDH2 gene mutation. It is phase 1 in which 6 out of 7 patients have shown positive results. Taking part in this trial will delay starting Vidaza by about a month. Any comments please.
|
All times are GMT -4. The time now is 03:35 PM. |
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2025, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org